Tris(8‐hydroxyquinolinato)gallium(III)‐Loaded Copolymer Micelles as Cytotoxic Nanoconstructs for Cosolvent‐Free Organometallic Drug Delivery
Source abstract
Abstract
Therapeutically useful concentrations of the water-insoluble organometallic drug, tris(8-hydroxyquinolinato)gallium(III), are delivered to haematological cell lines without the need for toxic cosolvents. Delivery is by sequestration into aqueous micelles of a poly(ethylene glycol)/poly(propylene glycol)/poly(ethylene glycol) triblock copolymer using a facile method based on emulsion-mediated evaporation. The drug-loaded micelles function as a cell cycle inhibitor and cause cell death by a dose-dependent increase in apoptosis. Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Ferrocene Chemistry and Applications · Dendrimers and Hyperbranched Polymers · Metal-Organic Frameworks: Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (25)
Show source-provided references
1. 10.1039/B707077M10.1039/B707077M ↗
2. 10.1039/b514859f10.1039/b514859f ↗
3. Collery P. · Anticancer Res. · 1996 · 16 · 687
4. Jakupec M. A. · Met. Ions Biol. Med. · 2008 · 10 · 110
5. Thiel M. · Contrib. Oncol. · 1999 · 43910.1159/000425857 ↗
6. 10.1097/CMR.0b013e32832b272d10.1097/CMR.0b013e32832b272d ↗
7. Valiahdi S. M. · Mol. Cancer Ther. · 2007 · 6 · 3426S
8. 10.1016/j.jinorgbio.2006.07.00310.1016/j.jinorgbio.2006.07.003 ↗
9. Kedar U. · Nanomed.‐Nanotechnol. Biol. Med. · 6 · 71410.1016/j.nano.2010.05.005 ↗
10. 10.1016/j.jconrel.2008.01.01810.1016/j.jconrel.2008.01.018 ↗
11. 10.1007/s11095-006-9223-y10.1007/s11095-006-9223-y ↗
12. 10.1016/j.colsurfb.2009.03.02710.1016/j.colsurfb.2009.03.027 ↗
13. 10.1016/j.ijpharm.2009.04.03010.1016/j.ijpharm.2009.04.030 ↗
14. 10.3109/1083745970902262310.3109/10837459709022623 ↗
15. 10.1016/j.biomaterials.2009.06.00410.1016/j.biomaterials.2009.06.004 ↗
16. 10.1039/b903837j10.1039/b903837j ↗
17. 10.1021/cm049533n10.1021/cm049533n ↗
18. 10.1158/1535-7163.MCT-06-028510.1158/1535-7163.MCT-06-0285 ↗
19. Hedley D. W. · Cancer Res. · 1988 · 48 · 3014
20. Bernstein L. R. · Pharmacol. Rev. · 1998 · 50 · 66510.1016/S0031-6997(24)01383-8 ↗
21. 10.1097/01.cco.0000142071.22226.d210.1097/01.cco.0000142071.22226.d2 ↗
22. Chitambar C. R. · Cancer Res. · 1994 · 54 · 3224
23. Lundberg J. H. · Cancer Res. · 1990 · 50 · 6466
24. Jakupec M. A. · Met. Ions Biol. Syst. · 2004 · 42 · 42510.1201/b12414-13 ↗
25. 10.1016/S0891-5849(02)00901-210.1016/S0891-5849(02)00901-2 ↗